Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Perkins

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The International Journal on Drug Policy|June 9, 2021
Medicinal cannabis and driving: the intersection of health and road safety policyDaniel Perkins, Hugh Brophy, Iain S McGregor, et al.
Journal of Psychoactive Drugs|November 23, 2024
Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global DatasetDaniel Perkins, Jerome Sarris, Tessa Cowley-Court, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|August 29, 2023
The significance of historical troponin elevation in acute heart failure: Not as reassuring as previously assumedNicholas E Harrison, Robert Ehrman, Peter Pang, et al.
Journal of Psychopharmacology (Oxford, England)|July 11, 2020
Changes in inflammatory biomarkers are related to the antidepressant effects of AyahuascaNicole Leite Galvão-Coelho, Ana Cecília de Menezes Galvão, Raíssa Nóbrega de Almeida, et al.
BMJ Open|April 15, 2025
Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavementVanessa L Beesley, Tom J Kennedy, Fiona Maccallum, et al.
The International Journal of Neuropsychopharmacology|October 22, 2022
Default Mode Network Modulation by Psychedelics: A Systematic ReviewJames J Gattuso, Daniel Perkins, Simon Ruffell, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|June 13, 2024
Ayahuasca: A review of historical, pharmacological, and therapeutic aspectsSimon G D Ruffell, Max Crosland-Wood, Rob Palmer, et al.
Frontiers in Behavioral Neuroscience|November 21, 2022
Prophylactic action of ayahuasca in a non-human primate model of depressive-like behaviorMaria Lara Porpino de Meiroz Grilo, Geovan Menezes de Sousa, Lilían Andrade Carlos de Mendonça, et al.
The Australian and New Zealand Journal of Psychiatry|March 22, 2021
Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigmDaniel Perkins, Jerome Sarris, Susan Rossell, et al.
Journal of Clinical Psychopharmacology|December 20, 2024
Ketamine's Altered States Meta-Analysis: The Relationship Between Psychomimetic and Clinical Effects With Focus in DepressionVagner Deuel de O Tavares, Kaike Thiê da Costa Gonçalves, Maria Luiza de Morais Barros, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The International Journal on Drug Policy|June 9, 2021
Medicinal cannabis and driving: the intersection of health and road safety policyDaniel Perkins, Hugh Brophy, Iain S McGregor, et al.
Journal of Psychoactive Drugs|November 23, 2024
Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global DatasetDaniel Perkins, Jerome Sarris, Tessa Cowley-Court, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|August 29, 2023
The significance of historical troponin elevation in acute heart failure: Not as reassuring as previously assumedNicholas E Harrison, Robert Ehrman, Peter Pang, et al.
Journal of Psychopharmacology (Oxford, England)|July 11, 2020
Changes in inflammatory biomarkers are related to the antidepressant effects of AyahuascaNicole Leite Galvão-Coelho, Ana Cecília de Menezes Galvão, Raíssa Nóbrega de Almeida, et al.
BMJ Open|April 15, 2025
Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavementVanessa L Beesley, Tom J Kennedy, Fiona Maccallum, et al.
The International Journal of Neuropsychopharmacology|October 22, 2022
Default Mode Network Modulation by Psychedelics: A Systematic ReviewJames J Gattuso, Daniel Perkins, Simon Ruffell, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|June 13, 2024
Ayahuasca: A review of historical, pharmacological, and therapeutic aspectsSimon G D Ruffell, Max Crosland-Wood, Rob Palmer, et al.
Frontiers in Behavioral Neuroscience|November 21, 2022
Prophylactic action of ayahuasca in a non-human primate model of depressive-like behaviorMaria Lara Porpino de Meiroz Grilo, Geovan Menezes de Sousa, Lilían Andrade Carlos de Mendonça, et al.
The Australian and New Zealand Journal of Psychiatry|March 22, 2021
Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigmDaniel Perkins, Jerome Sarris, Susan Rossell, et al.
Journal of Clinical Psychopharmacology|December 20, 2024
Ketamine's Altered States Meta-Analysis: The Relationship Between Psychomimetic and Clinical Effects With Focus in DepressionVagner Deuel de O Tavares, Kaike Thiê da Costa Gonçalves, Maria Luiza de Morais Barros, et al.
Pageof 5